Tevogen Bio Holdings Inc. announced that it has entered into a share purchase agreement to issue 500 shares of Series A Preferred Stock of the company for an aggregate purchase price of $2,000,000 on February 14, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7847 USD | -0.93% | -1.10% | -92.95% |
05-13 | Investors Eye Key Inflation Data in Days Ahead as US Futures Trend Modestly Higher Monday | MT |
05-13 | Top Premarket Gainers | MT |
1st Jan change | Capi. | |
---|---|---|
-92.95% | 132M | |
+46.19% | 56.65B | |
-6.14% | 39.44B | |
+39.19% | 39.03B | |
-6.65% | 26.86B | |
+12.33% | 26.75B | |
-21.78% | 19.03B | |
-0.35% | 12.28B | |
+24.18% | 12.26B | |
+28.38% | 12.04B |
- Stock Market
- Equities
- TVGN Stock
- News Tevogen Bio Holdings Inc.
- Tevogen Bio Holdings Inc. announced that it expects to receive $2 million in funding